Buy Ibrutinib-API (CAS 936563-96-1) impurity reference standard from Spectrasynth Pharmachem. Custom synthesis available — enquire for pricing, COA and availability.
Application: Ibrutinib is used to treat chronic lymphocytic leukemia Waldenström's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, marginal zone lymphoma, and chronic graft vs host disease. It is a small molecule drug.